Szwarcberg Javier's Insider Trades & SAST Disclosures

Szwarcberg Javier's most recent trade in Spruce Biosciences Inc was a trade of 358,800 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 10, 2024.

Share

Note

This is a custom search result for pattern Szwarcberg Javier.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Spruce Biosciences Inc Board Meeting 52 week low	Szwarcberg Javier	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2024	358,800	358,800	-		-	Restricted Stock Units
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2024	358,800	466,121	-		0	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Szwarcberg Javier	Director, CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share.	10 Dec 2024	128,020	338,101	-	0.5	68,747	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2024	111,000	506,796	-		0	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2024	111,000	222,000	-		-	Restricted Stock Units
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2024	89,700	427,801	-		0	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Szwarcberg Javier	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2024	89,700	269,100	-		-	Restricted Stock Units
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share.	10 Dec 2024	39,605	467,191	-	0.4	15,394	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share.	10 Dec 2024	32,005	395,796	-	0.4	12,440	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2024	358,800	358,800	-		-	Restricted Stock Units
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	717,600	717,600	-		-	Restricted Stock Units
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Dec 2023	111,000	145,705	-		0	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Szwarcberg Javier	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Dec 2023	111,000	333,000	-		-	Restricted Stock Units
Spruce Biosciences Inc Board Meeting 52 week low	Szwarcberg Javier	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share.	14 Dec 2023	38,384	107,321	-	1.7	63,717	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.98 per share.	30 Jun 2023	20,000	34,705	-	1.0	19,550	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.93 per share.	30 Dec 2022	14,705	14,705	-	0.9	13,717	Common Stock
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Dec 2022	444,000	444,000	-		-	Restricted Stock Units
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	750,000	750,000	-		-	Employee Stock Option (right to buy)
Spruce Biosciences Inc Board Meeting 52 week low	Javier Szwarcberg	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	250,000	250,000	-		-	Employee Stock Option (right to buy)

Showing 1 to 19 of 19 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades